Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for ''
published presentations and documents on DocSlides.
Relapsed and Refractory Myeloma
by jane-oiler
Ruben Niesvizky. Myeloma Center. Myelomacenter.or...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Highlights in Multiple myeloma
by amber
How to treat. triple- or penta-refractory . Multip...
Case Discussion A 64-year old woman diagnosed with monoclonal
by faustina-dinatale
Case Discussion A 64-year old woman diagnosed wit...
Pomalidomide
by marina-yarberry
therapy in relapsed/refractory myeloma: . A UK m...
x0000x0000 xAttxachexd xBottxom xBBoxx
by evans
Chimeric Antigen Receptor Tcell TherapyClinical Gu...
Update on Diagnosis and Treatments
by joanne
of Multiple Myeloma. Kenneth C. Anderson, M.D.. J...
Psychological Refractory Period & Anticipation
by giovanna-bartolotta
Psychological Refractory Period . The delay in re...
What Factor’s influence reaction time??
by celsa-spraggs
What is the psychological refractory period?. How...
Brentuximab Vedotin.
by luanne-stotts
How and When Should it be Used in B and T cell Ly...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
The Impending D eath of Cancer: A Herculean Task Emerging Therapies 2016
by phoebe-click
The Impending D eath of Cancer: A Herculean Task...
Recurrent HL after Auto
by karlyn-bohler
T. ransplant . in CR on . B. rentuximab. . V. ed...
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
by windbey
δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...
The Impending D eath of Cancer:
by elina
A Herculean Task. Emerging Therapies 2016. Ruemu E...
Hodgkin Lymphoma in Children and
by maddoxjustin
Adolescents. Introduction . Hodgkin Lymphoma (HL...
Commissioning Policy
by williams
OFFICIAL 1 Clinical Tocilizumab for the treatment ...
Treatment of refractory patients with autoimmune liver diseases
by ashley
Iskren. . Kotzev. Medical University, Varna. ЛÐ...
Summary 2011 Founded 2010
by eliza
in Houston. Vision: To be the leader in the develo...
Load More...